Clinical trial
Hemodynamic Effects of Low Doses of Arginine Vasopressin in Early Septic Shock Stage
NCT02053675 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hemodynamic Effects of Low Doses of Arginine Vasopressin in Early Septic Shock Stage
- Lead sponsor
- Federal University of São Paulo
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2008
- Completion date
- Not reported
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock